DrugDashboards

Sennosides and Docusate Sodium

Sennosides and Docusate Sodium · SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1 · Tablet · Oral · American Health Packaging

NDC 60687-0622-01 · 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.0303 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.02$0.04Aug 2021Sep 2026$0.0303
62 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$0.91
#90 count
$2.73

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$4,638
881 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for docusate sodium and sennosides (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M007
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sennosides and Docusate Sodium (Tablet)

LabelerStrengthFirst seenLast seen
Elysium Pharmaceuticals LtdDOCUSATE SODIUM 50 mg/1; SENNA ALATA LEAF 8.6 mg/1Sep 3, 2026Sep 3, 2026
American Health PackagingSENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Bryant Ranch PrepackSENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Cardinal Health 107, LLCSENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Geri-Care Pharmaceutical CorpSENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Meijer, Inc.SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Rmt Health LlcSENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Strategic Sourcing Services LlcSENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1Aug 26, 2026Sep 2, 2026
Geri-Care Pharmaceutical CorpSENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 22, 2026
American Health PackagingSENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Bryant Ranch PrepackSENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Cardinal Health 107, LLCSENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Meijer, Inc.SENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Preferred Pharmaceuticals Inc.SENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Rmt Health LlcSENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Strategic Sourcing Services LlcSENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1Jul 22, 2026Aug 19, 2026
Geri-Care Pharmaceutical CorpDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 19, 2026
American Health PackagingDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026
Bryant Ranch PrepackDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026
Cardinal Health 107, LLCDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026
Meijer, Inc.DOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026
Preferred Pharmaceuticals Inc.DOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026
Rmt Health LlcDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026
Strategic Sourcing Services LlcDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sennosides and Docusate Sodium — NDC 60687-0622-01," retrieved September 3, 2026, https://drugdashboards.com/drug/60687062201.

Free to cite with attribution — see how the data is put together.